LAVA Therapeutics' Seed VC Round

LAVA Therapeutics raised a round of funding on May 23, 2018.

Lava Therapeutics' proprietary platform is focused on developing next generation γδ T cell engaging bispecific antibodies to treat cancer. Its immuno-oncology approach activates Vγ9Vδ2 T cells upo…

Articles about LAVA Therapeutics' Seed VC Round: